交易 Astria Therapeutics, Inc. - ATXS CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
價差 | - | ||||||||
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 20% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|
Astria Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0.5 |
總營業費用 | 194.976 | 37.435 | 27.088 | 26.371 | 27.594 |
銷售/一般/行政費用,總計 | 14.807 | 11.845 | 8.771 | 9.329 | 8.912 |
研究與開發 | 180.169 | 25.59 | 18.317 | 17.042 | 18.682 |
營業收入 | -194.976 | -37.435 | -27.088 | -26.371 | -27.094 |
利息收入(費用),非經營淨值 | 0.122 | 0.236 | 0.845 | 0.325 | -0.302 |
其他,淨值 | -0.058 | -0.101 | -0.05 | 0.176 | 0.032 |
稅前淨收入 | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
稅後淨收入 | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
未計算非常項目前的淨收益 | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
淨收入 | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
普通股股東可獲收益 (不含非經常性項目) | -219.349 | -37.3 | -26.293 | -25.87 | -27.364 |
普通股股東可獲收益 (含非經常性項目) | -219.349 | -37.3 | -26.293 | -25.87 | -27.364 |
攤薄淨收入 | -219.349 | -37.3 | -26.293 | -25.87 | -27.364 |
攤薄後加權平均股 | 8.92517 | 3.05864 | 1.86655 | 0.84249 | 0.36137 |
扣除特別項目的每股攤薄盈利 | -24.5764 | -12.195 | -14.0864 | -30.7067 | -75.7237 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -24.5764 | -12.195 | -14.0864 | -30.7067 | -75.7237 |
收入 | 0 | 0.5 | |||
非常規項目總計 | 0 | ||||
Total Adjustments to Net Income | -24.437 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 15.378 | 9.508 | 7.898 | 7.486 | 170.085 |
銷售/一般/行政費用,總計 | 5.02 | 3.815 | 4.11 | 4.008 | 2.88 |
研究與開發 | 10.358 | 5.693 | 3.788 | 3.478 | 167.205 |
營業收入 | -15.378 | -9.508 | -7.898 | -7.486 | -170.085 |
其他,淨值 | -0.001 | -0.016 | -0.008 | -0.02 | 0.001 |
稅前淨收入 | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
稅後淨收入 | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
未計算非常項目前的淨收益 | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
淨收入 | -15.323 | -9.491 | -7.871 | -7.466 | -170.084 |
普通股股東可獲收益 (不含非經常性項目) | -15.323 | -9.491 | -7.871 | -31.903 | -170.084 |
普通股股東可獲收益 (含非經常性項目) | -15.323 | -9.491 | -7.871 | -31.903 | -170.084 |
攤薄淨收入 | -15.323 | -9.491 | -7.871 | -31.903 | -170.084 |
攤薄後加權平均股 | 13.017 | 13.0598 | 12.8308 | 5.98022 | 3.7301 |
扣除特別項目的每股攤薄盈利 | -1.17716 | -0.72673 | -0.61345 | -5.33476 | -45.5977 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.17716 | -0.72673 | -0.61345 | -5.33476 | -45.5977 |
利息收入(費用),非經營淨值 | 0.056 | 0.033 | 0.035 | 0.04 | |
Total Adjustments to Net Income | 0 | 0 | -24.437 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流動資産總額 | 127.075 | 46.325 | 38.958 | 38.915 | 17.463 |
現金和短期投資 | 125.508 | 44.93 | 36.244 | 37.57 | 16.369 |
現金等價物 | 1.853 | 22.999 | 5.432 | 5.956 | 16.369 |
短期投資 | 39 | 20 | 26.345 | 22.276 | 0 |
Prepaid Expenses | 1.446 | 1.274 | 2.237 | 1.345 | 1.094 |
Total Assets | 127.514 | 47.456 | 41.78 | 39.169 | 17.897 |
Property/Plant/Equipment, Total - Net | 0.394 | 0.966 | 2.349 | 0.056 | 0.321 |
Property/Plant/Equipment, Total - Gross | 0.377 | ||||
Accumulated Depreciation, Total | -0.321 | ||||
Other Long Term Assets, Total | 0.045 | 0.165 | 0.473 | 0.198 | 0.113 |
Total Current Liabilities | 5.203 | 6.39 | 5.032 | 4.171 | 6.016 |
Accounts Payable | 1.557 | 1.544 | 1.197 | 1.408 | 0.773 |
Accrued Expenses | 3.646 | 4.846 | 3.835 | 2.763 | 2.432 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 2.479 | |||
Total Liabilities | 5.203 | 6.787 | 6.06 | 4.227 | 6.105 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Long Term Debt | 0 | ||||
Other Liabilities, Total | 0 | 0.397 | 1.028 | 0.056 | 0.089 |
Total Equity | 122.311 | 40.669 | 35.72 | 34.942 | 11.792 |
Common Stock | 0.013 | 0.02 | 0.012 | 0.007 | 0.024 |
Additional Paid-In Capital | 481.709 | 301.546 | 259.305 | 232.243 | 183.202 |
Retained Earnings (Accumulated Deficit) | -455.809 | -260.897 | -223.597 | -197.304 | -171.434 |
Other Equity, Total | 0 | 0 | -0.004 | 0 | |
Total Liabilities & Shareholders’ Equity | 127.514 | 47.456 | 41.78 | 39.169 | 17.897 |
Total Common Shares Outstanding | 13.017 | 3.34746 | 2.07227 | 0.11903 | 0.3941 |
Other Current Liabilities, Total | 0 | 0.332 | |||
Preferred Stock - Non Redeemable, Net | 96.398 | 0 | 0 | 0 | |
Cash | 84.655 | 1.931 | 4.467 | 9.338 | |
Other Current Assets, Total | 0.121 | 0.121 | 0.477 | ||
Total Preferred Shares Outstanding | 0.03146 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流動資産總額 | 114.221 | 127.075 | 134.522 | 140.052 | 147.684 |
現金和短期投資 | 112.816 | 125.508 | 131.777 | 139.52 | 146.92 |
現金等價物 | 46.687 | 86.508 | 131.777 | 139.52 | 146.92 |
短期投資 | 66.129 | 39 | 0 | 0 | 0 |
Prepaid Expenses | 1.121 | 1.446 | 2.624 | 0.411 | 0.643 |
Other Current Assets, Total | 0.284 | 0.121 | 0.121 | 0.121 | 0.121 |
Total Assets | 114.653 | 127.514 | 135.129 | 140.945 | 148.74 |
Property/Plant/Equipment, Total - Net | 0.228 | 0.394 | 0.557 | 0.717 | 0.874 |
Other Long Term Assets, Total | 0.204 | 0.045 | 0.05 | 0.176 | 0.182 |
Total Current Liabilities | 4.967 | 5.203 | 4.7 | 3.988 | 4.406 |
Accounts Payable | 0.931 | 1.557 | 0.574 | 0.619 | 1.809 |
Accrued Expenses | 4.036 | 3.646 | 4.126 | 3.369 | 2.597 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4.967 | 5.203 | 4.7 | 4.046 | 9.004 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 0 | 0 | 0.058 | 4.598 | |
Total Equity | 109.686 | 122.311 | 130.429 | 136.899 | 139.736 |
Preferred Stock - Non Redeemable, Net | 96.398 | 96.398 | 96.398 | 99.77 | 240.881 |
Common Stock | 0.013 | 0.013 | 0.013 | 0.077 | 0.023 |
Additional Paid-In Capital | 484.46 | 481.709 | 480.336 | 475.499 | 329.813 |
Retained Earnings (Accumulated Deficit) | -471.132 | -455.809 | -446.318 | -438.447 | -430.981 |
Total Liabilities & Shareholders’ Equity | 114.653 | 127.514 | 135.129 | 140.945 | 148.74 |
Total Common Shares Outstanding | 13.017 | 13.017 | 13.0095 | 12.8248 | 3.90283 |
Total Preferred Shares Outstanding | 0.03146 | 0.03146 | 0.03146 | 0.03255 | |
Other Equity, Total | -0.053 | 0 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
淨收入/起跑線 | -194.912 | -37.3 | -26.293 | -25.87 | -27.364 |
經營活動産生的現金 | -30.151 | -32.485 | -26.569 | -23.465 | -26.836 |
經營活動産生的現金 | 0.026 | 0.119 | 0.304 | ||
非現金物品 | 168.066 | 1.448 | 1.568 | 1.524 | 2.158 |
已付現金利息 | 0 | 0.079 | 0.327 | ||
營運資金的變化 | -3.305 | 3.367 | -1.87 | 0.762 | -1.934 |
投資活動産生的現金 | -12.555 | 6.3 | -4.082 | -21.905 | 14.883 |
資本支出 | -0.021 | -0.033 | -0.012 | 0 | -0.057 |
其他投資現金流量項目,總計 | -12.534 | 6.333 | -4.07 | -21.905 | 14.94 |
融資活動産生的現金 | 104.284 | 40.86 | 25.62 | 44.295 | 4.726 |
股票的發行(報廢),淨額 | 104.284 | 40.86 | 25.62 | 47.143 | 8.059 |
債務的發行(退還),淨額 | 0 | -2.848 | -3.333 | ||
現金淨變化 | 61.578 | 14.675 | -5.031 | -1.075 | -7.227 |
融資現金流項目 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.323 | -194.912 | -185.421 | -177.55 | -170.084 |
Cash From Operating Activities | -12.559 | -30.151 | -23.865 | -16.116 | -8.716 |
Non-Cash Items | 2.672 | 168.066 | 166.702 | 165.302 | 165.037 |
Changes in Working Capital | 0.092 | -3.305 | -5.146 | -3.868 | -3.669 |
Cash From Investing Activities | -27.099 | -12.555 | 26.445 | 26.445 | 26.445 |
Capital Expenditures | 0 | -0.021 | -0.021 | -0.021 | -0.021 |
Other Investing Cash Flow Items, Total | -27.099 | -12.534 | 26.466 | 26.466 | 26.466 |
Cash From Financing Activities | 0 | 104.284 | 104.267 | 104.261 | 104.261 |
Issuance (Retirement) of Stock, Net | 0 | 104.284 | 104.267 | 104.261 | 104.261 |
Net Change in Cash | -39.658 | 61.578 | 106.847 | 114.59 | 121.99 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 12.1867 | 3351514 | 2974069 | 2022-12-31 | LOW |
Perceptive Advisors LLC | Private Equity | 7.9613 | 2189462 | 908265 | 2022-12-31 | MED |
Fairmount Funds Management LLC | Hedge Fund | 6.9138 | 1901397 | 989661 | 2022-12-31 | HIGH |
Deep Track Capital LP | Hedge Fund | 6.6052 | 1816531 | 1816531 | 2022-12-31 | MED |
Vivo Capital, LLC | Venture Capital | 6.1132 | 1681199 | 681199 | 2022-12-31 | MED |
Cormorant Asset Management, LP | Hedge Fund | 5.9997 | 1650000 | 450000 | 2022-12-31 | MED |
Altium Capital Management LP | Investment Advisor/Hedge Fund | 4.9284 | 1355372 | 910372 | 2022-12-31 | HIGH |
Driehaus Capital Management, LLC | Investment Advisor/Hedge Fund | 4.8627 | 1337315 | 680954 | 2022-12-31 | MED |
Logos Global Management LLC | Investment Advisor | 3.1452 | 864960 | 864960 | 2022-12-31 | HIGH |
Ikarian Capital LLC | Hedge Fund | 2.4551 | 675176 | -24264 | 2022-12-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.3793 | 654326 | 123173 | 2022-12-31 | LOW |
Rosalind Advisors, Inc. | Hedge Fund | 2.376 | 653438 | 653438 | 2021-12-31 | LOW |
Tri Locum Partners LP | Hedge Fund | 2.3684 | 651330 | 19751 | 2022-12-31 | HIGH |
Affinity Asset Advisors LLC | Hedge Fund | 1.718 | 472482 | 72439 | 2022-12-31 | HIGH |
Sphera Funds Management Ltd. | Hedge Fund | 1.7066 | 469340 | 469340 | 2022-12-31 | HIGH |
Ghost Tree Capital, LLC | Hedge Fund | 1.6363 | 450000 | -50000 | 2022-12-31 | HIGH |
Violin (Jonathan) | Individual Investor | 0.9575 | 263321 | 0 | 2022-04-13 | LOW |
Opaleye Management Inc. | Hedge Fund | 0.9516 | 261703 | 128203 | 2022-12-31 | MED |
Medical Strategy GmbH | Investment Advisor | 0.9185 | 252605 | -18814 | 2022-09-30 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 0.8181 | 225000 | 225000 | 2022-12-31 | HIGH |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Industry: | Bio Therapeutic Drugs |
75 State Street
Suite 1400
BOSTON
MASSACHUSETTS 02109
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 500.000 多名交易者,選擇與 Capital.com 交易